Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2002 Dec;94(12):1071–1076.

Chronic obstructive pulmonary disease in OAUTHC Ile-Ife: a ten-year review of hospital mortality.

G E Erhabor 1, O A Kolawole 1, O O Adewole 1
PMCID: PMC2568408  PMID: 12510706

Abstract

Chronic obstructive pulmonary disease (COPD) is a spectrum of chronic lung disease. The prevalence and incidence of COPD is on the increase globally with an attendant increase in morbidity and mortality. There is a lack of data on the prevalence and incidence of chronic obstructive pulmonary disease COPD in developing countries, which is what prompted this study. We reviewed mortality due to COPD in order to identify risk factors for death and possible preventive measures. Out of 161 admissions during the review period-1990 to 1999-there were 41 deaths, accounting for a mortality rate of 25.46%. The highest mortality occurred in the sixth and seventh decades of life with a male to female ratio of 3:1. Chest infections, cor pulmonale, and respiratory failure were the most common complications. Extremes of age, lower socio-economic group, smoking (>10 packs per year), and respiratory tract infection were the most commonly identified risk factors for death. Attention should be paid to preventive measures to halt the development and progression of the disease. This offers the best hope of minimizing mortality.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthonisen N. R., Connett J. E., Kiley J. P., Altose M. D., Bailey W. C., Buist A. S., Conway W. A., Jr, Enright P. L., Kanner R. E., O'Hara P. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994 Nov 16;272(19):1497–1505. [PubMed] [Google Scholar]
  2. Barnes P. J. Chronic obstructive pulmonary disease. N Engl J Med. 2000 Jul 27;343(4):269–280. doi: 10.1056/NEJM200007273430407. [DOI] [PubMed] [Google Scholar]
  3. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994 Oct 8;309(6959):901–911. doi: 10.1136/bmj.309.6959.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Holland W. W. Chronic obstructive lung disease prevention. Br J Dis Chest. 1988 Jan;82(1):32–44. doi: 10.1016/0007-0971(88)90006-x. [DOI] [PubMed] [Google Scholar]
  5. Jorenby D. E., Leischow S. J., Nides M. A., Rennard S. I., Johnston J. A., Hughes A. R., Smith S. S., Muramoto M. L., Daughton D. M., Doan K. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999 Mar 4;340(9):685–691. doi: 10.1056/NEJM199903043400903. [DOI] [PubMed] [Google Scholar]
  6. Keenan S. P., Kernerman P. D., Cook D. J., Martin C. M., McCormack D., Sibbald W. J. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. Crit Care Med. 1997 Oct;25(10):1685–1692. doi: 10.1097/00003246-199710000-00018. [DOI] [PubMed] [Google Scholar]
  7. Lopez A. D., Murray C. C. The global burden of disease, 1990-2020. Nat Med. 1998 Nov;4(11):1241–1243. doi: 10.1038/3218. [DOI] [PubMed] [Google Scholar]
  8. McCrory D. C., Brown C., Gelfand S. E., Bach P. B. Management of acute exacerbations of COPD: a summary and appraisal of published evidence. Chest. 2001 Apr;119(4):1190–1209. doi: 10.1378/chest.119.4.1190. [DOI] [PubMed] [Google Scholar]
  9. Mehta S., Hill N. S. Noninvasive ventilation. Am J Respir Crit Care Med. 2001 Feb;163(2):540–577. doi: 10.1164/ajrccm.163.2.9906116. [DOI] [PubMed] [Google Scholar]
  10. Organized jointly by the American Thoracic Society, the European Respiratory Society, the European Society of Intensive Care Medicine, and the Société de Réanimation de Langue Française, and approved by ATS Board of Directors, December 2000 International Consensus Conferences in Intensive Care Medicine: noninvasive positive pressure ventilation in acute Respiratory failure. Am J Respir Crit Care Med. 2001 Jan;163(1):283–291. doi: 10.1164/ajrccm.163.1.ats1000. [DOI] [PubMed] [Google Scholar]
  11. Pauwels R. A., Buist A. S., Calverley P. M., Jenkins C. R., Hurd S. S., GOLD Scientific Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001 Apr;163(5):1256–1276. doi: 10.1164/ajrccm.163.5.2101039. [DOI] [PubMed] [Google Scholar]
  12. Plant P. K., Owen J. L., Elliott M. W. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet. 2000 Jun 3;355(9219):1931–1935. doi: 10.1016/s0140-6736(00)02323-0. [DOI] [PubMed] [Google Scholar]
  13. Rennard S. I., Serby C. W., Ghafouri M., Johnson P. A., Friedman M. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. Chest. 1996 Jul;110(1):62–70. doi: 10.1378/chest.110.1.62. [DOI] [PubMed] [Google Scholar]
  14. Saint S., Bent S., Vittinghoff E., Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA. 1995 Mar 22;273(12):957–960. [PubMed] [Google Scholar]
  15. Schols A. M., Slangen J., Volovics L., Wouters E. F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1791–1797. doi: 10.1164/ajrccm.157.6.9705017. [DOI] [PubMed] [Google Scholar]
  16. Sherk P. A., Grossman R. F. The chronic obstructive pulmonary disease exacerbation. Clin Chest Med. 2000 Dec;21(4):705–721. doi: 10.1016/S0272-5231(05)70179-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Silagy C., Mant D., Fowler G., Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet. 1994 Jan 15;343(8890):139–142. doi: 10.1016/s0140-6736(94)90933-4. [DOI] [PubMed] [Google Scholar]
  18. Stanbrook M. B., Goldstein R. S. Steroids for acute exacerbations of COPD : how long is enough? Chest. 2001 Mar;119(3):675–676. doi: 10.1378/chest.119.3.675. [DOI] [PubMed] [Google Scholar]
  19. Stoller James K. Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002 Mar 28;346(13):988–994. doi: 10.1056/NEJMcp012477. [DOI] [PubMed] [Google Scholar]
  20. Wilson D. O., Rogers R. M., Openbrier D. Nutritional aspects of chronic obstructive pulmonary disease. Clin Chest Med. 1986 Dec;7(4):643–656. [PubMed] [Google Scholar]
  21. Wolkove N., Dajczman E., Colacone A., Kreisman H. The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest. 1989 Dec;96(6):1247–1251. doi: 10.1378/chest.96.6.1247. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES